Live tape
Top 8, mentions 7d10,448TSLA2,124 mentions▲ +0.05GOOGL1,638 mentions▲ +0.04CRWV1,303 mentions▲ +0.03NVDA1,264 mentions▲ +0.07SPCX1,156 mentions▲ +0.07QQQ1,130 mentions▲ +0.05META926 mentions▲ +0.05NBIS907 mentions▲ +0.05

Equity · Healthcare

APVO

NASDAQ

Aptevo Therapeutics Inc.

$1.62 −4.71% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
Price · Chart
62 sessions
$5 $1 21 Jul 16 Oct

The line runs $4.41 on 21 July through $1.62 on 16 October, on a scale from $1 to $5. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 62 sessions, 21 Jul – 16 Oct 2026
Market cap $2.9M
Avg volume 1.9K

as of Oct 16, 2026

APVO insider trades

SEC Form 4

APVO has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 10 November 2025.

Date Insider Type Shares Value
10 Nov 2025 Grant Grady III Buy 13,513 $20K

APVO reported financials

SEC EDGAR XBRL SEC EDGAR

APVO reported net income of −$26.0M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$26.0M 31 Dec 2025 fiscal year
Diluted EPS −$87.27 31 Dec 2025 fiscal year
Total assets $14.5M 30 Jun 2026 at period end
Total equity $6.0M 30 Jun 2026 at period end

APVO earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$5.31 —
31 Mar 2026 Q1 2026 −$6.41 —
31 Dec 2025 FY 2025 −$87.27 —
30 Sep 2025 Q3 2025 −$2.23 —
30 Jun 2025 Q2 2025 −$151.29 —
31 Mar 2025 Q1 2025 −$1,581.81 —
31 Dec 2024 FY 2024 −$31,460.23 —
30 Sep 2024 Q3 2024 −$357.86 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

APVO institutional holders

SEC Form 13F SEC EDGAR

0 of the 45 institutional funds we track reported a APVO position for the quarter ended 31 Dec 2025; the latest of those filings landed 17 Feb 2026.

Fund Action Shares Value
Point72 Asset Management Exited

APVO fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 1,954 shares of APVO failed to deliver (about $4K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
30 Sep 2026 1,954 $4K 0.108%
29 Sep 2026 1,958 $4K 0.109%
16 Sep 2026 44 $75 0.002%
15 Sep 2026 6,490 $12K 0.360%
11 Sep 2026 1,310 $2K 0.073%
10 Sep 2026 44,671 $83K 2.479%
09 Sep 2026 46,130 $87K 2.560%
08 Sep 2026 5,830 $10K 0.324%
04 Sep 2026 124,973 $214K 6.935%

Congressional trades in APVO

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in APVO is a sale by Steve Cohen (house, TN), dated 24 Jun 2019.

Date Member Type Amount
24 Jun 2019 filed 03 Jul 2019 Steve Cohen house · Democrat–TN Sale $470+

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings